Heather Howard arrived at Princeton with an unusual amount of hands-on policy experience. Throughout her career, Howard has maintained a clear focus on health equity, with an emphasis on expanding health insurance coverage and creative strategies to improve health outcomes for all.

During the winter break between the 2022-23 academic year semesters, The Office of the Dean of the College's Program for Community-Engaged Scholarship (ProCES) partnered with the New Jersey Alliance for Clinical and Translational Science (NJ…

Associate Professor of Psychology and Neuroscience Timothy Buschman has been awarded NJ ACTS pilot project funding for a one-year research study: Quantifying the dynamics of working memory in people with schizophrenia.

He will be collaborating with Co-Principal Investigator Professor David Zald from Rutgers University and…

NJ ACTS is pleased to announce the fifth year of our NIH-funded clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due March 22, 2023 by 5 pm. Applications are due April 14, 2023 by 5 pm.

Please review the 'Become a TL1 Fellow'…

Experimental challenges are not the only hurdles that must be surmounted before a new discovery can reach the patients and policymakers who need it. Read the full story.

NJ ACTS is soliciting applications from junior faculty for its Institutional Career Development (KL2) program. The new class of KL2 Scholars will be appointed starting July 1, 2023. To learn more about the program and award provisions, visit the career development&nbsp…

It might not look like much — a plastic box that fits in the hand, with tiny tubes jutting out the top and bottom. Too simple to be cutting edge. Too humble to save so many lives.

But for 20 years, researchers in Robert Prud’homme’s lab have fine-tuned this little box that has revolutionized drug manufacturing,…

A team of researchers from Princeton University and the Broad Institute of MIT and Harvard have created an easy-to-use diagnostic test for COVID infection that is more sensitive than the commonly used at-home antigen tests, and that also allows for the rapid and specific detection of SARS-CoV-2 variants in point-of-care settings.

Learn how two groups of Princeton researchers, including NJ ACTS TL1 fellow Tom Zajdel and his mentor Daniel Cohen, developed The People’s Ventilator: a fully open, low-cost, pressure-controlled ventilator research platform compatible with adult and pediatric uses. Read the story and the published paper. 

The NJ ACTS 2022 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $100,000 available.

The NJ ACTS 2022 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $100,000 available. Please see the Pilot Program Grants page for more details and to review the Request for Applications. Required Letters of Intent are due May 6 and applications are due June 17. 

Funding will advance discovery of novel anti-infectives addressing antimicrobial resistance.

ArrePath, a drug discovery spinout founded by Zemer Gitai, the Edwin Grant Conklin Professor of Biology…

NJ ACTS is pleased to announce the NIH-funded clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due March 31, 2022 by 5 pm. Applications are due April 22, 2022 by 5 pm.

Please visit the Become a TL1 Fellow section of the 

A Princeton-led technology to improve the storage and transport of vaccines and life-saving drugs at room temperature has been selected as one of three university innovations to receive funding for further development from the Philadelphia-based University City Science Center. The technology was developed by Princeton Research Scholar 

Christos Suriano, a postdoctoral researcher in the Princeton Neuroscience Institute (PNI), was awarded a prestigious TL1 fellowship from the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).

Suriano, who works in the lab of Lisa Boulanger, associate professor of…

Two members of Princeton's Molecular Biology Department, graduate student Esmat Hegazi (Muir lab) and postdoctoral researcher Rebecca Kim-Yip (Toettcher and Posfai labs), recently joined the NIH-funded NJ ACTS TL1…

The 2021 Partnership & Innovation Accelerator Pilot Program provides up to $10,000 to facilitate collaboration with local organizations on health research that benefits our communities. Learn more and read the Request for Application here. Letters of Intent are required and due July 23,…

NJ ACTS is pleased to announce a clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due April 30, 2021 by 5 pm. Applications are due May 27, 2021 by 5 pm.

Please visit the 

The NJ ACTS 2021 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 4 categories for potential pilot projects with awards up to $110,000 available.

Susan Leggett, a postdoctoral research associate in chemical and biological engineering, has received a two-year fellowship from the New Jersey Alliance for Clinical and Translational Science. The fellowship will allow her to develop her skills as a translational scientist, advance her cancer research, and provide mentoring by physician…

Due to the pandemic deaths last year, life expectancy at birth for Americans will shorten by 1.13 years to 77.48 years, according to a study co-authored by Noreen Goldman of Princeton SPIA, and published in the Proceedings of the National Academy of Sciences. That is the largest single-year decline in life expectancy in…

Talk to Princeton Postdoctoral Research Fellow Tom J. Zajdel long enough, and the egalitarian streak comes out.

Zajdel, 30, who has been at the University’s School of Mechanical & Aerospace Engineering for nearly two years, spent plenty of time during our conversation discussing electrical stimulation and environmental biosensing…

NJ ACTS is soliciting applications from junior faculty for its Institutional Career Development (KL2) program. The second class of KL2 Scholars will be appointed starting July 1, 2021. To learn more about the program, award provisions, eligibility criteria and requirements, and application instructions, 

NJ ACTS is pleased to announce a clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. 

Please visit the Training Awards page to review the program overview and Request for Applications, and to access the Application due July 3.

Spurred by the COVID-19 pandemic, Princeton researchers have developed a diagnostic tool to analyze chest X-rays for patterns in diseased lungs. The new tool could give doctors valuable information about a patient’s condition, quickly and cheaply, at the point of care. 

Read about the Rutgers Health Care Worker Corona Cohort Study, Princeton's efforts to design simplified ventilators and NJIT's pathogen resistant PPE. 

In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19.

The NJ ACTS Biostatistics, Epidemiology and Research Design (BERD) Core is pleased to announce a call for applications for the Year 2 BERD Mini-Methods Grants Program.

BERD is soliciting proposals for one-year awards of up to $25,000 from investigators developing methodology in study design, measurement, statistical analysis, and…

The NJ ACTS 2020 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $110,000 available.

NJ ACTS is excited to announce the awardees of the 2019 Partnership and Innovation Accelerator Pilot Grant Program (PIAP), Usha Ramachandran, MD and Helmut Zarbl, PhD. Continue to read full…

New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

Organized by that consortium, the New Jersey Alliance for Clinical and Translational Science (NJACTS) –…

A team led by the Rutgers Institute for Translational Medicine and Science that includes Princeton University and the New Jersey Institute of Technology has received a National Institutes of Health grant for $29 million over five years for joining the NIH's Clinical and Translational Science Awards Program (CTSA). The CTSA program at Rutgers…